プロモーションスケジュール Neoleukin Therapeutics, Inc.
詳細なスケジュール
簡易グラフ
会社について Neoleukin Therapeutics, Inc.
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc. さらに詳しく| IPO date | 2014-03-07 |
|---|---|
| ISIN | US64049K1043 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.neoleukin.com |
| Цена ао | 15.1 |
| 1日あたりの価格変動: | 0% (15.1) |
|---|---|
| 週ごとの価格変動: | 0% (15.1) |
| 月ごとの料金変更: | 0% (15.1) |
| 3ヶ月間の価格変動: | 0% (15.1) |
| 半年間の価格変動: | 0% (15.1) |
| 年間の価格変動: | 0% (15.1) |
| 3年間の価格推移: | +197.24% (5.08) |
| 5年間の価格推移: | +335.16% (3.47) |
| 10年間の価格推移: | 0% (15.1) |
| 年初からの価格変動: | 0% (15.1) |
|
|
過小評価
|
効率
|
|||||||||||||||||||||||||||||||||||||
配当金
|
義務
|
成長の衝動
|
|||||||||||||||||||||||||||||||||||||
| 機関 | 音量 | 共有, % |
|---|---|---|
| Baker Brothers Advisors, LLC | 1221414 | 13 |
| Redmile Group, LLC | 582443 | 6.2 |
| Adage Capital Partners GP L.L.C. | 310000 | 3.3 |
| Nantahala Capital Management, LLC | 299999 | 3.19 |
| Bank of America Corporation | 231779 | 2.47 |
| Vanguard Group Inc | 201539 | 2.14 |
| Renaissance Technologies, LLC | 163447 | 1.74 |
| Morgan Stanley | 107671 | 1.15 |
| Bml Capital Management, LLC | 98664 | 1.05 |
| Blackrock Inc. | 96613 | 1.03 |
| スーパーバイザー | 役職 | 支払い | 生年 |
|---|---|---|---|
| Ms. Donna M. Cochener-Metcalfe J.D. | Gen. Counsel & Sr. VP of Legal | 403.75k | 1975 (50 年) |
| Mr. Sean Michael Smith | Principal Accounting Officer, VP of Fin. & Controller | N/A | 1986 (39 年) |
| Dr. Jonathan G. Drachman M.D. | CEO, Pres, Principal Financial Officer & Director | 1962 (63 年) | |
| Dr. Priti Patel M.D., M.S. | Chief Medical Officer | 1976 (49 年) | |
| Dr. David Baker | Co-founder & Member of Scientific Advisory Board | ||
| Dr. Carl Walkey Ph.D. | Sr. VP of Corp. Devel. | 1985 (40 年) | |
| Mr. Kamran Alam | Sr. Strategic Advisor | 1974 (51 年) | |
| Dr. Bill Arthur | VP & Head of Research | ||
| Mr. Umut Ulge | VP of Clinical Devel. |
住所: United States, Seattle. WA, 188 East Blaine Street - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.neoleukin.com
Webサイト: https://www.neoleukin.com
